These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27254267)

  • 1. Type B insulin resistance syndrome.
    Willard DL; Stevenson M; Steenkamp D
    Curr Opin Endocrinol Diabetes Obes; 2016 Aug; 23(4):318-23. PubMed ID: 27254267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune forms of hypoglycemia.
    Lupsa BC; Chong AY; Cochran EK; Soos MA; Semple RK; Gorden P
    Medicine (Baltimore); 2009 May; 88(3):141-153. PubMed ID: 19440117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.
    Malek R; Chong AY; Lupsa BC; Lungu AO; Cochran EK; Soos MA; Semple RK; Balow JE; Gorden P
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3641-7. PubMed ID: 20484479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of type B insulin resistance with rituximab.
    Manikas ED; Isaac I; Semple RK; Malek R; Führer D; Moeller LC
    J Clin Endocrinol Metab; 2015 May; 100(5):1719-22. PubMed ID: 25675382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving clinical course of patients with insulin receptor autoantibodies: spontaneous remission or receptor proliferation with hypoglycemia.
    Flier JS; Bar RS; Muggeo M; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1978 Nov; 47(5):985-95. PubMed ID: 263346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Mediated Extreme Insulin Resistance: A Report of Three Cases.
    Kim HN; Fesseha B; Anzaldi L; Tsao A; Galiatsatos P; Sidhaye A
    Am J Med; 2018 Jan; 131(1):102-106. PubMed ID: 28822702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Two Autoimmune Dysglycemia Syndromes: Insulin Autoimmune Syndrome (IAS) and Type B Insulin Resistance Syndrome (B-IRS).
    Yu S; Yang G; Dou J; Wang B; Gu W; Lv Z; Ba J; Mu Y; Lu J
    Horm Metab Res; 2019 Nov; 51(11):723-728. PubMed ID: 31683342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperalimentation as cause of markedly worsened metabolic control in a patient with autoantibodies to the insulin receptor.
    Vesely DL; Coleman MJ; Kohler PO; Jordan RM; Stanley S
    Am J Med; 1985 Oct; 79(4):504-8. PubMed ID: 3931471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Ketoacidosis Without Diabetes.
    Willard D; Upadhyay J; Kim C; Steenkamp D
    J Clin Endocrinol Metab; 2016 Nov; 101(11):3870-3873. PubMed ID: 27636019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Syndromes of severe insulin resistance].
    Araki S
    Nihon Rinsho; 1999 Mar; 57(3):617-21. PubMed ID: 10199143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type B insulin resistance syndrome: a systematic review.
    Martins LM; Fernandes VO; Carvalho MMD; Gadelha DD; Queiroz PC; Montenegro Junior RM
    Arch Endocrinol Metab; 2020 Aug; 64(4):337-348. PubMed ID: 32813762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type B insulin resistance syndrome associated with an immune reconstitution inflammatory syndrome in an HIV-infected woman.
    Mohammedi K; Roussel R; El Dbouni O; Potier L; Abi Khalil C; Capel E; Vigouroux C; Caron-Debarle M; Capeau J; Marre M
    J Clin Endocrinol Metab; 2011 Apr; 96(4):E653-7. PubMed ID: 21270328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndromes of autoimmunity and hypoglycemia. Autoantibodies directed against insulin and its receptor.
    Taylor SI; Barbetti F; Accili D; Roth J; Gorden P
    Endocrinol Metab Clin North Am; 1989 Mar; 18(1):123-43. PubMed ID: 2645123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type B Insulin Resistance in Peru.
    Zelada H; Gamarra D; Arbañil H; Manrique H
    Am J Med Sci; 2017 Mar; 353(3):258-262. PubMed ID: 28262212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
    Arioglu E; Andewelt A; Diabo C; Bell M; Taylor SI; Gorden P
    Medicine (Baltimore); 2002 Mar; 81(2):87-100. PubMed ID: 11889410
    [No Abstract]   [Full Text] [Related]  

  • 16. Type B Insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia.
    Bourron O; Caron-Debarle M; Hie M; Amoura Z; Andreelli F; Halbron M; Fonfrede M; Leroux G; Vigouroux C; Hartemann A
    Lancet; 2014 Oct; 384(9953):1548. PubMed ID: 25390580
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunosuppressive Therapy in Treatment of Refractory Hypoglycemia in Type B Insulin Resistance: A Case Report.
    Viswanathan L; Sirisena I
    J Endocr Soc; 2017 Dec; 1(12):1435-1439. PubMed ID: 29264467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin autoimmune syndrome: from diagnosis to clinical management.
    Censi S; Mian C; Betterle C
    Ann Transl Med; 2018 Sep; 6(17):335. PubMed ID: 30306074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS; Johnson JL; Elliott-Mills D; Opas LM
    Lupus; 1997; 6(3):275-8. PubMed ID: 9104736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generalized acanthosis nigricans related to type B insulin resistance syndrome: a case report.
    Jeong KH; Oh SJ; Chon S; Lee MH
    Cutis; 2010 Dec; 86(6):299-302. PubMed ID: 21284281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.